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Case-Control Study of Clinical Features of Influenza
in Hospitalized Patients
Hilary M. Babcock, MD; Liana R. Merz, PhD; Erik R. Dubberke, MD; Victoria J. Fraser, MD
background. The symptoms of influenza infection in outpatients are well described. The Centers for Disease Control and Prevention
(CDC) definition of an influenza-like illness (ILI) includes fever and cough or sore throat. Few data exist on the clinical presentation of
influenza in hospitalized patients, which may be distinct from the clinical presentation of influenza in ambulatory patients because of
underlying medical conditions and medications.
design. Retrospective case-control study.
setting. A 1,250-bed urban teaching hospital.
patients. A total of 369 patients were admitted to the general medicine wards during 3 consecutive influenza seasons (2001–2004):
123 case patients with laboratory-confirmed influenza that was diagnosed during routine medical care and 246 control patients with active
surveillance culture results negative for influenza.
methods. Data on demographic characteristics, comorbidities, and signs and symptoms were obtained from a review of the medical
records of the case and control patients. Analysis included stratified analysis and logistic regression.
results. Cough, coryza, sore throat, and fever were more common in patients with influenza infection. The CDC’s definition of an
ILI had a sensitivity of 43% and specificity of 86% in the study population, with a crude odds ratio (OR) of 4.7 (95% confidence interval
[CI], 2.8–7.8). The sensitivity of the CDC’s definition of an ILI decreased to 21% among asthmatic patients, who had similar rates of fever
and/or ILI with or without influenza. By logistic regression, ILI was strongly associated with influenza infection in patients without asthma
(adjusted OR, 7.5 [95% CI, 4.1–13.7]) but not in patients with asthma (adjusted OR, 1.1 [95% CI, 0.13–10]). The positive predictive value
of an ILI in asthmatic patients was 50%.
conclusions. The CDC’s definition of an ILI lacks sensitivity among hospitalized patients, and the presence of an ILI is not associated
with influenza infection in asthmatic patients.
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Influenza epidemics in the United States result in an average
of 36,000 deaths and 114,000 hospitalizations annually.1 The
clinical characteristics of influenza infection have been well
described for outpatients,2-7 emergency department patients,8,
9 and nursing home residents.10 Several different case defini-
tions have been proposed for influenza in those
populations.2,4,5,11-14 The most commonly identified symptoms
are fever and cough, but these symptoms are not seen in all
cases. There are fewer data on the clinical presentation of hos-
pitalized patients found to have influenza,15-21 and many studies
used symptom-screening criteria that may have resulted in an
overrepresentation of common symptoms.
We hypothesized that hospitalized patients are less likely
to have classic symptoms of influenza-like illness (ILI). We
were specifically interested in the effect of age and chronic
pulmonary disease, such as emphysema and asthma, for
which the common presence of a cough could limit the dis-
criminating ability of the traditional ILI criteria as defined
by the Centers for Disease Control and Prevention (CDC).
methods
Study design. We conducted a retrospective case-control
study of patients hospitalized at a large, adult teaching hos-
pital during the study period from 2001 to 2004, which en-
compassed 3 consecutive influenza seasons. Influenza seasons
were defined as the period starting from the date of the first
laboratory-confirmed case of influenza in the hospital each
winter to the date of the last laboratory-confirmed case the
following spring. Institutional review board approval for the
project was obtained.
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table 1. Demographic Characteristics of Case and Control Pa-
tients Admitted to the General Medicine Wards of an Urban Teach-
ing Hospital During 3 Consecutive Influenza Seasons (2001–2004)
Characteristic






Age x65 years 67 (55) 105 (43) .03
Female sex 80 (65) 131 (53) .03
African American race 72 (58) 96 (39) .04
Disease or condition
Asthma 24 (20) 24 (10) !.01
Immunosuppression 29 (24) 38 (15) .06
Diabetes 34 (28) 104 (42) !.01
Chronic kidney disease 14 (11) 83 (34) !.01
Congestive heart failure 20 (16) 69 (28) .01
COPD 26 (25) 54 (22) .54
Cirrhosis 3 (2) 18 (7) .06
Cancer 10 (8) 17 (7) .67
note. COPD, chronic obstructive pulmonary disease.
Study Population
Case patients. Case patients ( ) were defined as in-np 123
patients admitted to the general medicine wards (2001–2004)
who were found to have laboratory-confirmed influenza in-
fection during routine medical care. Laboratory confirmation
included a positive direct fluorescent antibody test from a
nasal swab sample or, if that test result was negative, a positive
culture result from a nasal sample plated onto a monkey
kidney cell plate. All testing was performed at the virology
laboratory of St. Louis Children’s Hospital (St. Louis, MO).
Control patients. In the latter 2 years of the study period
(2002–2004), an active surveillance program was started, in
which all consenting patients admitted to the general med-
icine wards during influenza season were tested, regardless
of clinical symptoms or diagnosis at admission. During a
control patient’s hospitalization, nasal swab samples were ob-
tained for culture on admission and then on a weekly basis.
Overall, 410 patients were approached for participation; 75
refused. No patients, other than those identified during rou-
tine care, had influenza virus infection diagnosed during sur-
veillance testing. Of the 335 consenting patients known not
to have influenza, 246 were randomly selected to serve as
control patients, in a 2 : 1 ratio with case patients.
Data collection and covariates. Data on case and control
patients were collected by retrospective chart review of elec-
tronic and paper medical records using a standardized data
collection instrument. Age was dichotomized for analysis into
less than 65 years of age and 65 years of age or older, according
to CDC definitions of age groups at high risk for influenza.
Data on race was categorized as white, African American, and
other; data on sex were also collected.
Data on the presence or absence on admission of the fol-
lowing signs and symptoms commonly associated with in-
fluenza were collected from each patient’s medical chart:
cough, sore throat, “feverish” (patient reported), runny nose
and/or coryza, headache, muscle and/or body ache, chills and/
or rigors, fatigue, and fever. ILI was defined as fever and
cough or sore throat, according to the CDC’s surveillance
definition.22 Inpatients’ temperatures documented in the
medical records were reviewed; patients were considered feb-
rile if they had a documented temperature of 37.8C or higher
prior to the in-hospital diagnosis of influenza (case patients)
or prior to obtaining nasal swab samples for culture (control
patients). Data on the presence or absence of symptoms atyp-
ical for influenza, which included nausea, vomiting, and di-
arrhea, were also collected.
Medical covariates included congestive heart failure,
asthma, chronic obstructive pulmonary disease (emphysema
or chronic bronchitis), diabetes, renal failure, liver disease
(cirrhosis), cancer (with treatment in the last year), and an
immunosuppressed state (eg, due to receipt of oral steroids,
receipt of a transplant, or HIV infection). The covariates were
considered present if they were recorded in the admission
history, in the past medical history, or in the diagnostic as-
sessment and treatment plan.
Analysis. The percentage of case and control patients with
specific demographic characteristics, comorbid medical con-
ditions, and clinical signs and symptoms was calculated.
Among case patients, differences in clinical presentation by
influenza type (A, B, or C) and by the sex and age of the
patient were examined. The or Fischer exact tests were2x
performed to determine if any differences were statistically
significant (2-tailed testing; ). Crude odds ratios (ORs)P ! .05
were calculated to determine the strength of association be-
tween the CDC definition of an ILI and the laboratory-con-
firmed influenza; 95% confidence intervals (CIs) were cal-
culated to estimate the precision of the crude OR. The
sensitivity, specificity, and positive and negative predictive
values of the signs and symptoms of an ILI for laboratory-
confirmed influenza were calculated.
Effect modification by presence of asthma, presence of
chronic obstructive pulmonary disease, and older age was
assessed with the Breslow-Day test for homogeneity. Mantel-
Haenszel adjusted ORs were calculated if confounding was
detected. Multivariate adjustment for effect modification and
confounding was made with logistic regression analysis. The
Hosmer-Lemeshow test was used to assess the fit of the model.
All analyses were performed with SPSS, version 12 (SPSS).
results
There were 123 case patients with laboratory-confirmed in-
fluenza on the general medicine wards during the 3 influenza
seasons. The total study population included those 123 case
patients, who had influenza diagnosed during routine medical
care, and 246 control patients. Control patients were ran-
domly selected from patients whose nasal swab samples tested
influenza in hospitalized patients 923
table 2. Clinical Characteristics of Case and Control Patients Admitted
to the General Medicine Wards of an Urban Teaching Hospital During 3
Consecutive Influenza Seasons (2001–2004)
Characteristic






Cough 112 (91) 94 (38) !.01
Subjective fever (patient reported) 81 (66) 87 (35) !.01
Documented fevera 61 (50) 72 (29) !.01
Myalgias 42 (34) 38 (15) !.01
Coryza 36 (29) 35 (14) !.01
Sore throat 27 (22) 17 (7) !.01
Headache 34 (28) 56 (23) .30
Nausea or vomiting 46 (37) 111 (45) .16
Diarrhea 23 (19) 84 (34) !.01
Fever and cough 53 (43) 34 (14) !.01
Fever and sore throat 9 (7) 8 (3) .08
Fever and cough or sore throatb 53 (43) 34 (14) !.01
a Temperature x37.8C.
b Symptoms of influenza-like illness.
negative for influenza during active surveillance on the gen-
eral medicine wards. The demographic characteristics of case
and control patients are displayed in Table 1. Case patients
were more likely to be 65 years of age or older, female, and
African American. Asthma was more common in case pa-
tients, although there was no difference between case and
control patients in the proportion that had chronic obstruc-
tive pulmonary disease. Immunosuppression was slightly
more common in case patients, although the difference did
not reach statistical significance ( ). Congestive heartPp .06
failure, diabetes, kidney disease, and cirrhosis were more
common in control patients.
Clinical characteristics differed between case and control
patients (Table 2). The most typical symptoms of influenza
were more commonly found in case patients than in control
patients; these included cough, subjective and documented
fever, myalgias, coryza, and sore throat. Cough was the most
common symptom among case patients, and sore throat was
the least common. Among case patients, there was no dif-
ference in clinical presentation between patients with influ-
enza type A virus and patients with influenza type B virus,
between men and women, between patients from each of the
3 influenza seasons, or between patients less than 65 years
of age and patients 65 years of age or older. Control patients
were more likely to have diarrhea than were case patients.
There was no difference between groups in the proportion
of patients with headache and nausea or vomiting.
The combination of fever and sore throat, although un-
common in both groups, was slightly more common in the
case patients than in control patients (9 [7%] of 123 vs 8
[3%] of 246; ). The combination of fever and coughPp .08
was significantly more common in case patients than in con-
trol patients (53 [43%] of 123 vs 34 [14%] of 246; ).P ! .01
For case patients, the crude OR of having an ILI was 4.7
(95% CI, 2.8–7.8). By stratified analysis, asthma was found
to be an effect modifier: for case patients with asthma, the
adjusted OR of having an ILI decreased to 1.0 (95% CI, 0.2–
4.0). Congestive heart failure and chronic renal disease were
more common in control patients than in case patients and
were found to be confounders on stratified analysis. Chronic
obstructive pulmonary disease, age, race, and sex were not
found to have any significant association with ILI.
A logistic regression model was built using ILI, asthma,
congestive heart failure, and chronic renal disease as risk
factors. According to this model, for case patients without
asthma, the OR for meeting the case definition of an ILI was
7.5 (95% CI, 4.1–13.7). For case patients with asthma, how-
ever, the OR for meeting the case definition of an ILI was
1.1 (95% CI, 0.13–10.0). Further review of the 48 asthmatic
patients (24 case patients and 24 control patients) revealed
that, although cough was somewhat more common among
case patients than among control patients (23 [96%] of 24
vs 18 [75%] of 24; ), the prevalence of fever wasPp .097
the same for both case and control patients (5 [21%] of 24
vs 6 [25%] of 24; ). The prevalence of ILI-definingPp .73
symptoms was also identical (5 [21%] of 24 vs 5 [21%] of
24).
Overall, the use of ILI-defining symptoms to detect influ-
enza in hospitalized patients has a sensitivity of 43% and a
specificity of 86%, with a positive predictive value of 61%
and a negative predictive value of 75% (Table 3). Cough alone
had the best sensitivity (91%). Fever with sore throat had the
best specificity (97%). Documented fever alone had a sen-
sitivity of 50%. Among asthmatic patients, the sensitivity of
the ILI definition was only 21%, with a specificity of 79%,
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table 3. Use of Symptoms of Influenza-Like Illness (ILI) to Detect Influenza in Patients
Admitted to the General Medicine Wards of an Urban Teaching Hospital During 3 Consecutive
Influenza Seasons (2001–2004)
Patient group, symptom Sensitivity, % Specificity, % PPV, % NPV, %
Case and control patients ( )np 369
Documented fevera 50 71 46 73
Cough 91 62 54 93
Sore throat 22 93 61 70
Fever and cough 43 86 61 75
Fever and sore throat 7 97 53 68
ILI 43 86 61 75
Patients with asthma ( )bnp 48
ILI 21 79 50 50
note. NPV, negative predictive value; PPV, positive predictive value.
a Temperature ≥37.8C.
b There were 24 case patients and 24 control patients.
and the positive and negative predictive values of the ILI-
defining symptoms were both 50%.
discussion
Our study reviewed the clinical presentation of influenza in
hospitalized patients during 3 influenza seasons in a large
midwestern teaching hospital using case-control methodol-
ogy. This research builds on work reported previously20 in
which we described the clinical presentation of influenza in
hospitalized patients by looking at a case series of 207 in-
patients with influenza. The current study was limited to
patients on the general medicine wards, to allow for com-
parison with a control population of patients on the general
medicine wards known not to have influenza.
The ILI symptom complex lacked sensitivity in this patient
population. In contrast to other studies,8,16,18,23 this study
found no effect of age on presentation. Cough alone had the
highest sensitivity (91%), while fever had a sensitivity of 50%.
Our data suggest that, during influenza season, the presence
of cough in a hospitalized patient should prompt testing for
influenza, even in the absence of fever. We did not find any
differences in the prevalence of the ILI-defining symptoms
by season or influenza type (A or B).
For the asthmatic patients in this study, it was found that
the ILI symptoms were simply not associated with influenza
infection, by multivariate analysis. Contrary to our expec-
tation, this difference appeared to be related to the low rates
of fever in this population, not to high rates of cough. The
low prevalence of fever in this population (21%) may be
related to long-term use of steroids, either oral or inhaled;
however, this information is unavailable because data on out-
patient medication were not collected in this study.
Several outpatient studies have reported higher sensitivity
for the ILI-defining symptoms of cough with fever, ranging
from 50% to 95%,4,6,7 with positive predictive values ranging
from 40% to 87%.2,4,6 The higher sensitivity of these symp-
toms for outpatients supports our hypothesis that hospital-
ized patients may have less typical clinical presentations of
influenza infection. Alternatively, the use of fever and/or up-
per respiratory symptoms as inclusion criteria for influenza
testing in most of these studies may have resulted in them
missing less typical presentations.
There are limited data on the clinical presentation of in-
fluenza in hospitalized patients. Two inpatient studies re-
ported the clinical presentation of influenza among elderly
patients.15,17 One study found that 65% of the patients had a
fever higher than 38C,15 and another found a sensitivity of
78% for the combination of fever, cough, and acute onset.17
Both studies used inclusion criteria for influenza screening
that included an ILI or a respiratory illness, which may ex-
plain the higher rates of those symptoms. A recent prospective
cohort study in The Netherlands also found a low sensitivity
of cough and fever (35%) in hospitalized patients.21 All pa-
tients admitted during the study period were tested for in-
fluenza, including those without suspected ILI or respiratory
illness. Similar to that of our study, this design provides an
asymptomatic comparison group and more realistic calcu-
lations of sensitivity and positive predictive value.
Although the increased risk for influenza and for compli-
cations from influenza among asthmatic patients is well doc-
umented, there are few data that report the clinical presen-
tation of influenza in those patients. One study performed
prospective surveillance for viral respiratory infections with
respiratory syncitial virus, adenovirus, parainfluenza, and in-
fluenza in 104 outpatient asthmatic and nonasthmatic chil-
dren.24 Viral testing was performed for both groups, regardless
of whether there were current symptoms of an upper respi-
ratory infection. The authors found that asthmatic children
had a higher rate of viral infection than did nonasthmatic
children, regardless of clinical symptoms at the time of the
test.24 This result supports our finding that clinical sympto-
matology may be an unreliable guide to the presence of in-
fluenza infection in asthmatics, although more studies are
influenza in hospitalized patients 925
needed of larger cohorts of asthmatic patients and of adult
patients.
This study has several limitations. Because of the retro-
spective data collection, some data of interest could not be
reliably obtained, including duration of symptoms, smoking
history, and influenza vaccination status. The adequate cap-
ture of data on clinical symptoms relied on both the patient’s
reporting and the healthcare worker’s recording of the in-
formation. A standardized data collection tool was used by
trained data collectors to maximize our ability to find re-
ported symptoms from the medical chart; the same system
was used for case and control patients, to minimize any bias.
Bias in the reporting of symptoms by patients or their health-
care providers cannot be detected.
In addition, the sensitivity of laboratory testing for influ-
enza is dependent on the quality of the sample obtained, as
well as on the timing of sampling during the clinical course
of illness. Cases of influenza infection may have been missed
if the sample was not obtained properly or if the sample was
obtained late in the course of the disease. If this did occur,
some case patients might have been analyzed as control pa-
tients, thus lowering the observed OR for an ILI. In addition,
the low level of influenza activity during the study period
may have influenced the positive predictive value of the in-
fluenza symptoms examined. Also, not all case and control
patients were matched by year, because the surveillance pro-
gram started in year 2 of the study. Although we did not find
any differences in clinical presentation among case patients
by year, differences between case and control patients by year
could not be evaluated.
These findings have several important clinical implications.
In the absence of reliable case definitions to identify hospi-
talized patients with influenza, vaccination remains an im-
portant measure to prevent the nosocomial spread of disease.
Because vaccine mismatch with the circulating strain of the
influenza virus may leave even vaccinated patients vulnerable,
aggressive testing and early isolation are also critical to limit
spread. Cough was the most sensitive symptom, indicating
that a high clinical suspicion for influenza should be main-
tained for all patients admitted with cough during influenza
season, regardless of other symptoms.
Among asthmatic patients, the presence of the ILI-defining
symptoms had no correlation with influenza infection. Pa-
tients with asthma are at high risk for influenza infection and
for complications from influenza. Vaccination remains the
best defense, and screening criteria for influenza in asthmatic
patients are needed. Until more data are available, consid-
eration should be given to performing influenza testing on
all patients with asthma admitted to the hospital during in-
fluenza season, regardless of suggestive symptoms. More work
is needed to define predictive symptomatology for influenza
infection among inpatients, in general, and among inpatients
with asthma, in particular.
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